STABLECOIN DEVELOPMENT CORP (SDEV) Stock Price & Overview
NYSEARCA:SDEV • US66987P5089
Current stock price
The current stock price of SDEV is 1.39 USD. Today SDEV is up by 0.72%.
SDEV Key Statistics
- Market Cap
- 37.016M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -12.67
- Dividend Yield
- 51.95%
SDEV Stock Performance
SDEV Stock Chart
SDEV Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to SDEV.
SDEV Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to SDEV. Both the profitability and financial health of SDEV have multiple concerns.
SDEV Earnings
SDEV Forecast & Estimates
For the next year, analysts expect an EPS growth of 39.01% and a revenue growth 11.73% for SDEV
SDEV Groups
Sector & Classification
SDEV Financial Highlights
Over the last trailing twelve months SDEV reported a non-GAAP Earnings per Share(EPS) of -12.67. The EPS increased by 98.17% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -95.27% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
SDEV Ownership
SDEV Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 26.35 | 853.191B | ||
| JNJ | JOHNSON & JOHNSON | 17.82 | 544.731B | ||
| MRK | MERCK & CO. INC. | 22.17 | 278.01B | ||
| PFE | PFIZER INC | 8.97 | 155.349B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.29 | 121.259B | ||
| ZTS | ZOETIS INC | 16.62 | 49.697B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.62 | 28.547B | ||
| VTRS | VIATRIS INC | 5.82 | 17.152B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 21.35 | 11.291B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 9.359B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 6.199B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 6.101B | ||
| CORT | CORCEPT THERAPEUTICS INC | 85.82 | 4.797B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the NYSE Arca Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About SDEV
Company Profile
NovaBay Pharmaceuticals Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Emeryville, California and currently employs 14 full-time employees. The company went IPO on 2007-10-26. NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The firm manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
Company Info
IPO: 2007-10-26
STABLECOIN DEVELOPMENT CORP
2000 Powell St Ste 1150
Emeryville CALIFORNIA US
Employees: 14
Phone: 15108998800
STABLECOIN DEVELOPMENT CORP / SDEV FAQ
What does STABLECOIN DEVELOPMENT CORP do?
NovaBay Pharmaceuticals Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Emeryville, California and currently employs 14 full-time employees. The company went IPO on 2007-10-26. NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The firm manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
What is the current price of SDEV stock?
The current stock price of SDEV is 1.39 USD. The price increased by 0.72% in the last trading session.
Does STABLECOIN DEVELOPMENT CORP pay dividends?
STABLECOIN DEVELOPMENT CORP (SDEV) has a dividend yield of 51.95%. The yearly dividend amount is currently 0.37.
What is the ChartMill technical and fundamental rating of SDEV stock?
SDEV has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the GICS sector and industry of SDEV stock?
STABLECOIN DEVELOPMENT CORP (SDEV) operates in the Health Care sector and the Pharmaceuticals industry.
How many employees does STABLECOIN DEVELOPMENT CORP have?
STABLECOIN DEVELOPMENT CORP (SDEV) currently has 14 employees.